An Extension Study of PF-05280586, a Potential Rituximab Biosimilar, versus Rituximab in Subjects with Active Rheumatoid Arthritis

Cohen, SB, Burgos-Vargas, R, Emery, P et al. (3 more authors) (2018) An Extension Study of PF-05280586, a Potential Rituximab Biosimilar, versus Rituximab in Subjects with Active Rheumatoid Arthritis. Arthritis Care and Research, 70 (11). pp. 1598-1606. ISSN 0893-7524

Abstract

Metadata

Authors/Creators:
  • Cohen, SB
  • Burgos-Vargas, R
  • Emery, P
  • Jin, B
  • Cronenberger, C
  • Vázquez-Abad, MD
Copyright, Publisher and Additional Information: © 2018, Pfizer Inc. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Dates:
  • Published: November 2018
  • Accepted: 17 April 2018
  • Published (online): 25 April 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 Apr 2018 10:18
Last Modified: 25 Apr 2019 00:39
Status: Published
Publisher: Wiley-Blackwell
Identification Number: https://doi.org/10.1002/acr.23586

Share / Export

Statistics